Incretin-Based Therapies and Diabetic Retinopathy: real-World Evidence in Older U.S
No adverse events have been reported to date
Products are sold under the "research chemical" or "not for human consumption" designation, which is a legal positioning that carries real risk: no GMP oversight is required, no adverse event reporting is required, and the consumer has no regulatory recourse if a product is mislabeled
The findings showed an increased risk of several gastrointestinal issues in patients using GLP-1 agonists for weight loss compared to those using bupropion-naltrexone
Role of ppar alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator wy-14,643
While there was an average reduction in bodyweight, a previous study on nutritional safety following LFD did not find any clinically meaningful changes in in macro- or micronutrient intake in spite of weight loss, indicating its relative safety (21)